Kck Ltd. Neuro Pace Inc Transaction History
Kck Ltd.
- $70.4 Million
- Q3 2023
A detailed history of Kck Ltd. transactions in Neuro Pace Inc stock. As of the latest transaction made, Kck Ltd. holds 5,621,111 shares of NPCE stock, worth $42.5 Million. This represents 77.74% of its overall portfolio holdings.
Number of Shares
5,621,111
Previous 5,621,111
-0.0%
Holding current value
$42.5 Million
Previous $25.2 Million
116.71%
% of portfolio
77.74%
Previous 39.59%
Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
61Shares Held
18.7MCall Options Held
28.9KPut Options Held
7.5K-
Orbimed Advisors LLC San Diego, CA4MShares$30.3 Million1.19% of portfolio
-
Morgan Stanley New York, NY2.48MShares$18.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$18.4 Million2.63% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT778KShares$5.88 Million0.66% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA644KShares$4.87 Million4.05% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $188M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...